Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1970 1
1972 1
1973 6
1974 9
1975 13
1976 8
1977 6
1978 4
1979 4
1980 7
1981 7
1982 10
1983 6
1984 11
1985 14
1986 10
1987 14
1988 14
1989 14
1990 16
1991 14
1992 25
1993 40
1994 23
1995 35
1996 36
1997 37
1998 56
1999 60
2000 50
2001 44
2002 44
2003 41
2004 20
2005 36
2006 32
2007 40
2008 20
2009 25
2010 27
2011 19
2012 26
2013 19
2014 24
2015 21
2016 14
2017 23
2018 14
2019 7
2020 6
2021 16
2022 7
2023 3
2024 8
2025 10
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,056 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Single inhaler with beclometasone, formoterol, and glycopyrronium versus triple therapies in adults with uncontrolled asthma: a systematic review and meta-analysis.
Braido F, Vlachaki I, Nikolaidis GF, Tzelis D, Barouma I, Piraino A, Madoni A, Scichilone N. Braido F, et al. Sci Rep. 2025 Feb 4;15(1):4191. doi: 10.1038/s41598-025-88374-w. Sci Rep. 2025. PMID: 39905183 Free PMC article.
The objective of this study was to determine the comparative efficacy of extra-fine single-inhaler medium-dose (MD) or high-dose (HD) of beclometasone/formoterol/glycopyrronium bromide (BDP/FOR/GLY) compared to other triple therapies in patients whose asthma remains uncont …
The objective of this study was to determine the comparative efficacy of extra-fine single-inhaler medium-dose (MD) or high-dose (HD) of …
Beclometasone Dipropionate/Formoterol Fumarate is Similarly Effective to Budesonide/Formoterol Fumarate in Chinese Patients with COPD: The FORSYYN Double-Blind, Randomised Study.
Wen F, Wu Y, Xing C, Zhu Y, Chen Y, Mei X, Corradi M, Cappellini G, Calabro E, Amodio S, Zhu C, Galkin D. Wen F, et al. COPD. 2024 Dec;21(1):2425157. doi: 10.1080/15412555.2024.2425157. Epub 2024 Nov 11. COPD. 2024. PMID: 39529298 Free article. Clinical Trial.
The fixed-dose combination of beclometasone dipropionate/formoterol fumarate (BDP/FF) delivered via pressurised metered-dose inhaler (pMDI) has demonstrated efficacy in chronic obstructive pulmonary disease (COPD), in studies predominantly conducted in Caucasian adults. .. …
The fixed-dose combination of beclometasone dipropionate/formoterol fumarate (BDP/FF) delivered via pressurised metered-dose inhaler …
Effects of inhaled beclometasone dipropionate/formoterol fumarate/glycopyrronium vs. beclometasone dipropionate/formoterol fumarate and placebo on lung hyperinflation and exercise endurance in chronic obstructive pulmonary disease: a randomised controlled trial.
Watz H, Kirsten AM, Ludwig-Sengpiel A, Krüll M, Mroz RM, Georges G, Varoli G, Charretier R, Cortellini M, Vele A, Galkin D. Watz H, et al. Respir Res. 2024 Oct 17;25(1):378. doi: 10.1186/s12931-024-02993-x. Respir Res. 2024. PMID: 39420338 Free PMC article. Clinical Trial.
BACKGROUND: The single-inhaler triple combination of beclometasone dipropionate, formoterol fumarate, and glycopyrronium (BDP/FF/G) is available for maintenance therapy of chronic obstructive pulmonary disease (COPD). ...
BACKGROUND: The single-inhaler triple combination of beclometasone dipropionate, formoterol fumarate, and glycopyrronium (BDP/FF/G) i …
Beclometasone for chronic obstructive pulmonary disease.
De Coster DA, Jones M, Thakrar N. De Coster DA, et al. Cochrane Database Syst Rev. 2013 Oct 9;2013(10):CD009769. doi: 10.1002/14651858.CD009769.pub2. Cochrane Database Syst Rev. 2013. PMID: 24105424 Free PMC article.
OBJECTIVES: To determine the effectiveness and safety in COPD of inhaled beclometasone alone compared with placebo, and of inhaled beclometasone in combination with LABAs compared with LABAs alone. ...AUTHORS' CONCLUSIONS: We found little evidence to suggest that …
OBJECTIVES: To determine the effectiveness and safety in COPD of inhaled beclometasone alone compared with placebo, and of inhaled …
Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial.
Papi A, Corradi M, Pigeon-Francisco C, Baronio R, Siergiejko Z, Petruzzelli S, Fabbri LM, Rabe KF. Papi A, et al. Lancet Respir Med. 2013 Mar;1(1):23-31. doi: 10.1016/S2213-2600(13)70012-2. Epub 2013 Mar 4. Lancet Respir Med. 2013. PMID: 24321801 Clinical Trial.
We compared the efficacy and safety of an extrafine combination inhaler containing a corticosteroid (beclometasone) plus a rapid-onset, long-acting beta2 agonist (formoterol) with a short-acting beta2 agonist (salbutamol) as reliever strategies in patients taking beclom …
We compared the efficacy and safety of an extrafine combination inhaler containing a corticosteroid (beclometasone) plus a rapid-onse …
Evaluating the pharmacokinetics of beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide delivered via pressurised metered-dose inhaler using a low global warming potential propellant.
Rony F, Cortellini M, Guasconi A, Mathews KS, Piccinno A, Poli G, Vanhoutte F, Klein J. Rony F, et al. Pulm Pharmacol Ther. 2024 Jun;85:102299. doi: 10.1016/j.pupt.2024.102299. Epub 2024 Apr 23. Pulm Pharmacol Ther. 2024. PMID: 38663512 Free article. Clinical Trial.
Switching to dry-powder inhalers may not be clinically feasible for all patients; an alternative is reformulation using propellants with low global warming potential. The combination of beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide (BDP/FF/GB) is av …
Switching to dry-powder inhalers may not be clinically feasible for all patients; an alternative is reformulation using propellants with low …
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial.
Papi A, Vestbo J, Fabbri L, Corradi M, Prunier H, Cohuet G, Guasconi A, Montagna I, Vezzoli S, Petruzzelli S, Scuri M, Roche N, Singh D. Papi A, et al. Lancet. 2018 Mar 17;391(10125):1076-1084. doi: 10.1016/S0140-6736(18)30206-X. Epub 2018 Feb 9. Lancet. 2018. PMID: 29429593 Clinical Trial.
We aimed to compare a single-inhaler triple combination of beclometasone dipropionate, formoterol fumarate, and glycopyrronium (BDP/FF/G) versus a single-inhaler dual bronchodilator combination of indacaterol plus glycopyrronium (IND/GLY) in terms of the rate of moderate-t …
We aimed to compare a single-inhaler triple combination of beclometasone dipropionate, formoterol fumarate, and glycopyrronium (BDP/F …
Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials.
Virchow JC, Kuna P, Paggiaro P, Papi A, Singh D, Corre S, Zuccaro F, Vele A, Kots M, Georges G, Petruzzelli S, Canonica GW. Virchow JC, et al. Lancet. 2019 Nov 9;394(10210):1737-1749. doi: 10.1016/S0140-6736(19)32215-9. Epub 2019 Sep 30. Lancet. 2019. PMID: 31582314 Clinical Trial.
Here we report on two studies that compared the single-inhaler extrafine combination of beclometasone dipropionate (BDP; inhaled corticosteroid), formoterol fumarate (FF; long-acting beta(2) agonist), and glycopyrronium (G; long-acting muscarinic antagonist) with the combi …
Here we report on two studies that compared the single-inhaler extrafine combination of beclometasone dipropionate (BDP; inhaled cort …
The impact of dosage timing for inhaled corticosteroids in asthma: a randomised three-way crossover trial.
Wang R, Maidstone R, Singh D, Ray D, Loudon AS, Simpson A, Durrington HJ. Wang R, et al. Thorax. 2025 Jul 15;80(8):504-511. doi: 10.1136/thorax-2024-222073. Thorax. 2025. PMID: 40234005 Free PMC article. Clinical Trial.
Participants with mild to moderate atopic asthma were randomised to beclometasone dipropionate: (1) 400 g once daily between 08:00 and 09:00 (OD(AM)); (2) 400 g once daily between 15:00 and 16:00 (OD(PM)); and (3) 200 g twice daily between 08:00 and 09:00 and between 20 …
Participants with mild to moderate atopic asthma were randomised to beclometasone dipropionate: (1) 400 g once daily between 08:00 a …
Pharmacokinetic profile of beclometasone dipropionate/formoterol fumarate administered through a novel dry-powder inhaler in Chinese healthy volunteers.
Luo Z, Lucci G, Santoro L, Topole E, Mariotti F. Luo Z, et al. Pulm Pharmacol Ther. 2022 Jun;73-74:102129. doi: 10.1016/j.pupt.2022.102129. Epub 2022 May 4. Pulm Pharmacol Ther. 2022. PMID: 35525480 Free article. Clinical Trial.
INTRODUCTION: An extrafine formulation of the inhaled corticosteroid beclometasone dipropionate (BDP) plus the long-acting beta(2)-agonist formoterol fumarate (FF) has been available for years via a pressurised metered-dose inhaler for the management of asthma and chronic …
INTRODUCTION: An extrafine formulation of the inhaled corticosteroid beclometasone dipropionate (BDP) plus the long-acting beta(2)-ag …
1,056 results